Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferriprotoporphyrin IX (free heme) is a toxic byproduct generated during the intraerythrocytic stage of the malaria parasite's life cycle, specifically when Plasmodium species digest host hemoglobin within their acidic food vacuole (Sullivan, 2002, PubMed). Because free heme can cause oxidative damage and membrane lysis, the parasite utilizes a biocrystallization pathway to convert it into an insoluble, non-toxic crystalline polymer called hemozoin (Egan, 2008, PubMed). This detoxification process is essential for parasite survival and represents a validated therapeutic target for several major classes of antimalarial medications (Hempelmann, 2007, PubMed). Drugs such as chloroquine and other quinolines interfere with this pathway by binding to heme monomers or crystal surfaces, effectively halting the formation of hemozoin (PubChem CID 4971). The resulting buildup of free heme-drug complexes induces lethal oxidative stress and disrupts the integrity of the parasite's digestive vacuole (Egan, 2008, PubMed). Consequently, targeting the heme biocrystallization pathway remains a cornerstone of malaria chemotherapy, although its efficacy is increasingly challenged by the emergence of resistant parasite strains (Sullivan, 2002, PubMed).
Inhibition of heme biocrystallization into hemozoin; formation of toxic heme-drug complexes; induction of oxidative stress and membrane damage within the parasite food vacuole.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferriprotoporphyrin IX (FPPIX) (FPPIX).